Home
>
US Stocks
>
Evolus Inc
Evolus Inc
EOLS

Evolus Inc

$7.6728.72%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.7
Today Low/High
7.64 / 7.85
52 Week Low/High
$2.85 / $17.38
P/E ratio
-4.1965
Market Cap
$551.22M

Company Details

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today.
Organisation
Evolus Inc
Headquaters
Newport Beach, California, United States
Employees
119
Industry
Health Technology
CEO
David Moatazedi

Discover more

Frequently Asked Questions

What is Evolus Inc share price today

Can Indians buy Evolus Inc shares?

How can I buy Evolus Inc shares from India?

Can Fractional shares of Evolus Inc be purchased?

What are the documents required to start investing in Evolus Inc stocks?

We are a SEBI registered investement advisor